Liquid Biopsy
Liquid biopsy may transform the ability to characterize, monitor lymphoma
Healio spoke with Ash A. Alizadeh, MD, PhD, associate professor, divisions of oncology & hematology, Stanford Cancer Institute, about the potential of liquid biopsy in lymphoma.
Circulating tumor cells predictive of relapse in stage III melanoma
Circulating tumor cells appeared independently associated with relapse among patients with stage III melanoma, according to results of a prospective study published in Clinical Cancer Research.
Oncologists must be ‘very cautious’ as liquid biopsy use expands
So-called “liquid biopsies” — noninvasive tests used to evaluate blood for cancer cells or DNA — have been refined extensively over the past decade, leading to a growing number of applications in cancer treatment.
Cell-free DNA may aid in early detection, monitoring of various cancer types
Cell-free DNA fragmentation profiles could be used for screening, early detection and monitoring of certain cancer types, study findings suggest.
Liquid biopsy shows efficacy for detection of microsatellite instability
Guardant360 — a liquid biopsy test through which next-generation sequencing is performed on cell-free DNA extracted from a patient’s blood — appeared effective for detection of microsatellite instability status, according to study data published in Clinical Cancer Research.